Both γδ T cells and NK cells inhibit the engraftment of xenogeneic rat bone marrow cells and the induction of xenograft tolerance in mice

B. Nikolic, David T Cooke, G. Zhao, M. Sykes

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

In murine allogeneic bone marrow transplantation recipients, treatment of the hosts with a nonmyeloablative regimen, including depleting anti-CD4 and anti-CD8 mAbs, allows establishment of long-term mixed chimerism and donor-specific tolerance. However, in the xenogeneic rat-to-mouse combination, additional anti-Thy1.2 and anti-NK1.1 mAbs are required. We have now attempted to identify the xenoresistant mouse cell populations that are targeted by anti-NK1.1 and anti-Thy1.2 mAbs. C57BL/6 (B6) wild-type, B6 TCRβ-/-, and B6 TCRδ-/- mice received anti-CD4 and anti-CD8 mAbs, followed by 3 Gy of whole body irradiation, 7 Gy of thymic irradiation, and transplantation of T cell-depleted rat bone marrow cells. Anti-NK1.1 and anti-Thy1.2 mAbs were additionally administered to some groups. Increased rat chimerism was observed in TCRδ-/- mice treated with anti-CD4, anti-CD8, and anti-NK1.1 mAbs compared with similarly treated TCRβ-/- mice. In TCRβ-/- mice, but not in TCR δ-/- mice, donor chimerism was increased by treatment with anti-Thy1.2 mAb, indicating that CD4-CD8-TCRγδ+Thy1.2+ NK1.1- cells (γδ T cells) are involved in the rejection of rat marrow. In addition, chimerism was enhanced in both TCRβ-/- and TCRδ-/- mice treated with anti-CD4, anti-CD8, and anti-Thy1.2 mAbs by the addition of anti-NK1.1 mAb to the conditioning regimen. Donor-specific skin graft prolongation was enhanced by anti-Thy1.2 and anti-NK1.1 mAbs in TCRδ-/- mice. Therefore, in addition to CD4 and CD8 T cells, γδ T cells and NK cells play a role in resisting engraftment of rat marrow and the induction of xenograft tolerance in mice.

Original languageEnglish (US)
Pages (from-to)1398-1404
Number of pages7
JournalJournal of Immunology
Volume166
Issue number2
StatePublished - Jan 15 2001
Externally publishedYes

Fingerprint

Heterografts
Natural Killer Cells
Bone Marrow Cells
Chimerism
Bone Marrow
Whole-Body Irradiation
Homologous Transplantation
Bone Marrow Transplantation
Transplantation
Transplants
Skin
Therapeutics

ASJC Scopus subject areas

  • Immunology

Cite this

Both γδ T cells and NK cells inhibit the engraftment of xenogeneic rat bone marrow cells and the induction of xenograft tolerance in mice. / Nikolic, B.; Cooke, David T; Zhao, G.; Sykes, M.

In: Journal of Immunology, Vol. 166, No. 2, 15.01.2001, p. 1398-1404.

Research output: Contribution to journalArticle

@article{995387dc10ab427c8a674faf50368069,
title = "Both γδ T cells and NK cells inhibit the engraftment of xenogeneic rat bone marrow cells and the induction of xenograft tolerance in mice",
abstract = "In murine allogeneic bone marrow transplantation recipients, treatment of the hosts with a nonmyeloablative regimen, including depleting anti-CD4 and anti-CD8 mAbs, allows establishment of long-term mixed chimerism and donor-specific tolerance. However, in the xenogeneic rat-to-mouse combination, additional anti-Thy1.2 and anti-NK1.1 mAbs are required. We have now attempted to identify the xenoresistant mouse cell populations that are targeted by anti-NK1.1 and anti-Thy1.2 mAbs. C57BL/6 (B6) wild-type, B6 TCRβ-/-, and B6 TCRδ-/- mice received anti-CD4 and anti-CD8 mAbs, followed by 3 Gy of whole body irradiation, 7 Gy of thymic irradiation, and transplantation of T cell-depleted rat bone marrow cells. Anti-NK1.1 and anti-Thy1.2 mAbs were additionally administered to some groups. Increased rat chimerism was observed in TCRδ-/- mice treated with anti-CD4, anti-CD8, and anti-NK1.1 mAbs compared with similarly treated TCRβ-/- mice. In TCRβ-/- mice, but not in TCR δ-/- mice, donor chimerism was increased by treatment with anti-Thy1.2 mAb, indicating that CD4-CD8-TCRγδ+Thy1.2+ NK1.1- cells (γδ T cells) are involved in the rejection of rat marrow. In addition, chimerism was enhanced in both TCRβ-/- and TCRδ-/- mice treated with anti-CD4, anti-CD8, and anti-Thy1.2 mAbs by the addition of anti-NK1.1 mAb to the conditioning regimen. Donor-specific skin graft prolongation was enhanced by anti-Thy1.2 and anti-NK1.1 mAbs in TCRδ-/- mice. Therefore, in addition to CD4 and CD8 T cells, γδ T cells and NK cells play a role in resisting engraftment of rat marrow and the induction of xenograft tolerance in mice.",
author = "B. Nikolic and Cooke, {David T} and G. Zhao and M. Sykes",
year = "2001",
month = "1",
day = "15",
language = "English (US)",
volume = "166",
pages = "1398--1404",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "2",

}

TY - JOUR

T1 - Both γδ T cells and NK cells inhibit the engraftment of xenogeneic rat bone marrow cells and the induction of xenograft tolerance in mice

AU - Nikolic, B.

AU - Cooke, David T

AU - Zhao, G.

AU - Sykes, M.

PY - 2001/1/15

Y1 - 2001/1/15

N2 - In murine allogeneic bone marrow transplantation recipients, treatment of the hosts with a nonmyeloablative regimen, including depleting anti-CD4 and anti-CD8 mAbs, allows establishment of long-term mixed chimerism and donor-specific tolerance. However, in the xenogeneic rat-to-mouse combination, additional anti-Thy1.2 and anti-NK1.1 mAbs are required. We have now attempted to identify the xenoresistant mouse cell populations that are targeted by anti-NK1.1 and anti-Thy1.2 mAbs. C57BL/6 (B6) wild-type, B6 TCRβ-/-, and B6 TCRδ-/- mice received anti-CD4 and anti-CD8 mAbs, followed by 3 Gy of whole body irradiation, 7 Gy of thymic irradiation, and transplantation of T cell-depleted rat bone marrow cells. Anti-NK1.1 and anti-Thy1.2 mAbs were additionally administered to some groups. Increased rat chimerism was observed in TCRδ-/- mice treated with anti-CD4, anti-CD8, and anti-NK1.1 mAbs compared with similarly treated TCRβ-/- mice. In TCRβ-/- mice, but not in TCR δ-/- mice, donor chimerism was increased by treatment with anti-Thy1.2 mAb, indicating that CD4-CD8-TCRγδ+Thy1.2+ NK1.1- cells (γδ T cells) are involved in the rejection of rat marrow. In addition, chimerism was enhanced in both TCRβ-/- and TCRδ-/- mice treated with anti-CD4, anti-CD8, and anti-Thy1.2 mAbs by the addition of anti-NK1.1 mAb to the conditioning regimen. Donor-specific skin graft prolongation was enhanced by anti-Thy1.2 and anti-NK1.1 mAbs in TCRδ-/- mice. Therefore, in addition to CD4 and CD8 T cells, γδ T cells and NK cells play a role in resisting engraftment of rat marrow and the induction of xenograft tolerance in mice.

AB - In murine allogeneic bone marrow transplantation recipients, treatment of the hosts with a nonmyeloablative regimen, including depleting anti-CD4 and anti-CD8 mAbs, allows establishment of long-term mixed chimerism and donor-specific tolerance. However, in the xenogeneic rat-to-mouse combination, additional anti-Thy1.2 and anti-NK1.1 mAbs are required. We have now attempted to identify the xenoresistant mouse cell populations that are targeted by anti-NK1.1 and anti-Thy1.2 mAbs. C57BL/6 (B6) wild-type, B6 TCRβ-/-, and B6 TCRδ-/- mice received anti-CD4 and anti-CD8 mAbs, followed by 3 Gy of whole body irradiation, 7 Gy of thymic irradiation, and transplantation of T cell-depleted rat bone marrow cells. Anti-NK1.1 and anti-Thy1.2 mAbs were additionally administered to some groups. Increased rat chimerism was observed in TCRδ-/- mice treated with anti-CD4, anti-CD8, and anti-NK1.1 mAbs compared with similarly treated TCRβ-/- mice. In TCRβ-/- mice, but not in TCR δ-/- mice, donor chimerism was increased by treatment with anti-Thy1.2 mAb, indicating that CD4-CD8-TCRγδ+Thy1.2+ NK1.1- cells (γδ T cells) are involved in the rejection of rat marrow. In addition, chimerism was enhanced in both TCRβ-/- and TCRδ-/- mice treated with anti-CD4, anti-CD8, and anti-Thy1.2 mAbs by the addition of anti-NK1.1 mAb to the conditioning regimen. Donor-specific skin graft prolongation was enhanced by anti-Thy1.2 and anti-NK1.1 mAbs in TCRδ-/- mice. Therefore, in addition to CD4 and CD8 T cells, γδ T cells and NK cells play a role in resisting engraftment of rat marrow and the induction of xenograft tolerance in mice.

UR - http://www.scopus.com/inward/record.url?scp=0035863755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035863755&partnerID=8YFLogxK

M3 - Article

VL - 166

SP - 1398

EP - 1404

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 2

ER -